Comparative study of combined treatment with systemic substance P and local stromal derived factor 1 alpha on recombinant human bone morphogenic protein 2- induced ectopic bone formation in a rat model.

Beshara, Nermine Fekry; Abd Elgawad, Hala Salah Eldin; Abd Elrahman, Eman Nabil; Abd Elmonsif, Doaa Ali; Kampschulte, Marian; Soliman, Gehan Yassin

doi:10.21608/besps.2022.176884.1132

	Comparative study of combined treatment with systemic substance P and local stromal derived factor 1 alpha on recombinant human bone morphogenic protein 2- induced ectopic bone formation in a rat model.
Bulletin of Egyptian Society for Physiological Sciences
Volume 43, Issue 2, April 2023, Page 124-141 PDF (996.24 K)
Document Type: Original Article
DOI: 10.21608/besps.2022.176884.1132
View on SCiNiTO
Authors
Nermine Fekry Beshara¹; Hala Salah Eldin Abd Elgawad²; Eman Nabil Abd Elrahman³; Doaa Ali Abd Elmonsif⁴; Marian Kampschulte⁵; Gehan Yassin Soliman ⁶
¹Medical Physiology department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
²Department of Medical Physiology Faculty of Medicine Alexandria University, Alexandria, Egypt
³Department of Histology & Cell Biology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
⁴Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt
⁵Department of Diagnostic and Interventional Radiology, University Hospital Giessen, Justus Liebig University, Giessen, Germany
⁶Medical Physiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Abstract
Abstract Introduction: Healing of bone defects represents clinical challenge due to limited effectiveness of available treatments. Enhancement of endogenous mesenchymal stem cells (MSCs) mobilization and homing is a promising approach for bone regeneration. The present study tested the hypothesis that stem cell mobilization and homing by systemic Substance P (SP) and local Stromal Cell-Derived Factor-1 (SDF-1α) treatment can augment low-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) induced ectopic bone formation in a rat model. Materials and Methods: Rats received intravenous injections of either saline or SP in implantation day as well as postoperative day 1 of the subcutaneous implantation of absorbable collagen sponges (ACS’s) loaded with saline or suboptimal dose of rhBMP-2 alone or suboptimal dose of rhBMP-2 and SDF-1α. At 28th days, bone formation in the explanted scaffolds was examined for alkaline phosphatase activity (ALP), osteopontin (OPN) assays as well as radiologically and histologically. Results: systemic SP and local SDF-1 α significantly enhanced ALP activity in the explanted bony nodules of the studied groups as compared to controls. Radiological and histological assessment were consistant with biochemical results showing much more mature bone formation. Conclusion: The study provides evidence of the effective treatment of systemic SP and local SDF-1 α in enhancement of in vivo trafficking of MSC’s in low-dose rhBMP induced ectopic bone formation.
Keywords
In situ bone regeneration; Substance P; Stromal Cell-Derived Factor-1 α Bone Morphogenic Protein-2


Statistics Article View: 207 PDF Download: 101